The prevalence of human immunodeficiency virus infection among TB patients in port Harcourt Nigeria

HIV/AIDS - Research and Palliative Care

Volumn 2, Issue , 2010, Pages 1-5

  Erhabor, O ^a   Jeremiah, Z A ^b   Adias, T C ^a   Okere, C E ^b  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b RIVERS STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Nigeria)

Author keywords

Acquired immunodeficiency syndrome aids; HIV; Human immunodeficiency virus; Nigeria; Port Harcourt; TB; Tuberculosis

Indexed keywords

EID: 77954562210     PISSN: None     EISSN: 11791373     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of TB. Am J Respir Crit Care Med. 2003; 167:603-662.
2. Low SY, Eng P. Human immunodeficiency virus testing in patients with newly-diagnosed TB in Singapore. Singapore Med Journal. 2009;50(5):479-481.
3. API consensus expert committee. API TB Consensus guidelines 2006. Management of pulmonary TB, extra-pulmonary TB and TB in special situations. J Assoc Physicians India. 2006;54:219-234.
4. Diagbouga S, Chazallon C, Kazatchkine MD, et al. Successful implementation of a low-cost method for the enumerating CD4 T-lymphocyte in resource limited setting: the ANRS 12-26 study. AIDS. 2003;17:2201-2208.
5. Yusuph H. Prevalence of HIV infection, in TB patient in Nguru, North Eastern Nigeria. Sahel Medical Journal. 2005;8(3):65-67.
6. Eriki PP, Okwere A, Aisu T. The Influence of human immunodeficiency virus infection of TB in Kampala, Uganda. Annual Review of Respiratory Diseases. 1991;40:128-132.
7. Daniel OJ, Salako AA, Oluwole FA, Alausa OK, Oladapo OT. Human immunodeficiency virus sero-prevalence among newly diagnosed adult pulmonary TB patients in sagamu, Nigeria. Nigeria Journal of Medicine. 2004;3(4):393-397.
8. Elliott AM, Lout N, Tembo G, et al. Impact of Human immunodeficiency virus on TB patients in Zambia, a cross-sectional study. BMJ. 1990;301(6749):412-415.
9. Van Gorkan J, Kibuga D, Achallah Adungesi J, et al. Human immunodeficiency virus sero prevalence among TB patients in Kenya. East Africa Medical Journal. 1999;76(8):752-456.
10. Van Cleef MR, Chum HJ. The proportion of TB cases in Tanzania attributable to human immunodeficiency virus. Int J Epidemiol. 1995; 24(3):637-642.
11. De Cock KM, Soro B, Coulibaly IM, Lucas SB. TB and HIV infection in sub-Saharan Africa. JAMA. 1992;268:1581-1587.
12. Haar CH, Cobelens FGJ, Kalisvaart NA, Van der Have JJ, Van Gerven PJ, Van Deuteron H. HIV prevalence among TB patients in the Netherlands, 1993-2001: trends and risk factors. Int J Tuberc Lung Dis. 2006;10(7):768-774.
13. Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of TB in the United States among HIV-infected persons. Ann Intern Med. 1997; 126:123-113.
14. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. TB in patients with human immunodeficiency virus infection. N Engl J Med. 1991; 324(23):1644-1650.
15. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of TB in the United States, 1985 through 1992. JAMA. 1994;272(7): 535-539.
16. Greenberg SD, Frager D, Suster B, Walker S, Stavropoulos C, Rothpearl A. Active pulmonary TB in patients with AIDS: spectrum of radiographic findings including a normal appearance. Radiology. 1994;193(1):115-119.
17. Geeta RG. How men's power over women fuels the HIV epidermic. Br Med J. 2002;423(7331):183-184.
18. Peter KL, Kriesten R, Willard C. HIV/AIDS evolving impact on global health. In: Ron Valdisern editior, Dawning answers. How the HIV/AID epidemic has strengthened public health. New York: Oxford Press; 2002.
19. Gomez AC, Marin VB. Gender, culture and power. Barriers to HIV-prevention strategies for women. J of Sex Res. 1996;33(4):355-362.
20. Ramachandran R, Datta M, Subramani R, Baskaran G, Paramasivan CN, Suamenathan S. Sero prevalence of Human immunodeficiency virus infection among TB patients in Tamil Nadu. Ind J of Med Res. 2003; 118:147-151.
21. Brenan CA, Bodelle P, Coffey R, et al. The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr. 2008;49(4):432-439.
22. Nyobi BM, Kristiansen KI, Bjune G, Muller F, Holm-Hansen C. Diversity of human immunodeficiency type 1 subtype in Kegera and Kilimanjaro regions, Tanzania. AIDS Res Hum Retroviruses. 2008; 24(6):761-769.
23. Pieniazek D, Ellenberger D, Janini LM, et al. Predominance of human immunodeficiency virus type 2 subtype in Abidjan, Ivory Coast. AIDS Res Hum Retroviruses. 1999;15(6):603-608.
24. Bonney EY, Sackey ST, Brandful JA. Laboratory diagnosis of dual HIV-1/HIV-2 infection in Ghanaian patients. East Afr Med J. 2008;85(11):537-543.
25. Shiman R, Hui Y, Yanwen Z, et al. Rising HIV prevalence among married and unmarried among men who have sex with men: Jinan, China. AIDS and Behav. 2009;13(4):671-676.
26. Shisana O, Zungu-Dirwayi N, Toefy Y, Simbavi LC, Malik S, Zuma K. Marital status and risk of HIV infection in South Africa. S Afr Med J. 2004;94(7):537-543.
27. Murrill CS, Prevots DR, Miller MS, Linley LA, Royalty JE, Gwinn M. Incidence of HIV among injection drug users entering drug treatment programs in four US cities. J Urban Health. 2001;78(1):152-161.
28. Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV: issues in methodology, interpretation, and prevention. Am Psychol. 1993;48:1035-1045.
29. Kalichman SC, Simbavi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007;8(2):141-151.